Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

A.A. Sandoo; T. Dimitroulas; A. Sandoo; J. Hodson; J. Smith; V.F. Panoulas; G.D. Kitas

doi:10.1016/j.atherosclerosis.2014.07.033

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

A.A. Sandoo
, T. Dimitroulas
, A. Sandoo
, J. Hodson
, J. Smith
, V.F. Panoulas
, G.D. Kitas

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Crynodeb

The aim of our study was to determine whether Dimethylarginine Dimethylaminohydrolase (DDAH) 1 and 2 gene polymorphisms – the main enzyme involved in ADMA degradation – are associated with high Asymmetric Dimethylarginine (ADMA) levels in Rheumatoid Arthritis (RA).

Iaith wreiddiol	Saesneg
Cyfnodolyn	Atherosclerosis
Cyfrol	237
Rhif cyhoeddi	1
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.1016/j.atherosclerosis.2014.07.033
Statws	Cyhoeddwyd - 27 Awst 2014

Mynediad at Ddogfen

10.1016/j.atherosclerosis.2014.07.033

Dyfynnu hyn

@article{27b17a5a1eff4783bd178252d1ad7643,

title = "Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis",

abstract = "The aim of our study was to determine whether Dimethylarginine Dimethylaminohydrolase (DDAH) 1 and 2 gene polymorphisms – the main enzyme involved in ADMA degradation – are associated with high Asymmetric Dimethylarginine (ADMA) levels in Rheumatoid Arthritis (RA).",

author = "A.A. Sandoo and T. Dimitroulas and A. Sandoo and J. Hodson and J. Smith and V.F. Panoulas and G.D. Kitas",

year = "2014",

month = aug,

day = "27",

doi = "10.1016/j.atherosclerosis.2014.07.033",

language = "English",

volume = "237",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

AU - Sandoo, A.A.

AU - Dimitroulas, T.

AU - Sandoo, A.

AU - Hodson, J.

AU - Smith, J.

AU - Panoulas, V.F.

AU - Kitas, G.D.

PY - 2014/8/27

Y1 - 2014/8/27

N2 - The aim of our study was to determine whether Dimethylarginine Dimethylaminohydrolase (DDAH) 1 and 2 gene polymorphisms – the main enzyme involved in ADMA degradation – are associated with high Asymmetric Dimethylarginine (ADMA) levels in Rheumatoid Arthritis (RA).

AB - The aim of our study was to determine whether Dimethylarginine Dimethylaminohydrolase (DDAH) 1 and 2 gene polymorphisms – the main enzyme involved in ADMA degradation – are associated with high Asymmetric Dimethylarginine (ADMA) levels in Rheumatoid Arthritis (RA).

U2 - 10.1016/j.atherosclerosis.2014.07.033

DO - 10.1016/j.atherosclerosis.2014.07.033

M3 - Article

SN - 0021-9150

VL - 237

JO - Atherosclerosis

JF - Atherosclerosis

IS - 1

ER -

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

Crynodeb

Mynediad at Ddogfen

Ôl bys

Dyfynnu hyn